ARCHIVES

FDA To Expand Disclosure For Advisory Committee Members

This article is from The Cancer Letter archive.

Vol. 36 No. 15 | April 23, 2010

Download PDF Visit The Full Archive

Related Articles

Murphy Puts RPMI On Record

July 22, 1977

Device Shortens Time To Make T Cells For Immunotherapy

March 27, 2009

Irinotecan And Carboplatin Improve Response In NSCLC

June 24, 2005

In Brief: Grants Compromise Still In Doubt As Natcher, Conte Hold Out for 6,500; House Marks Up Bill

July 12, 1985

In Brief: Cancer Control Funds For Clinical Trials Intended To Upgrade Quality of Care: Terry

January 16, 1981

OAM Director Jacobs To Leave; Cites “Conflict with Conscience”

July 15, 1994